Contact
Please use this form to send email to PR contact of this press release:
End Brain Cancer Initiative Looking to Partner with GBM Drug Development Companies to Help Fight for Patient Access
TO:
Dellann Elliott Mydland
End brain cancer Initiative
+1 425-444-2215